Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis.
Leung, Donald Y M; Paller, Amy S; Zaenglein, Andrea L; Tom, Wynnis L; Ong, Peck Y; Venturanza, May E; Kuligowski, Michael E; Li, Qian; Gong, Xiaohua; Lee, Mark S.
Afiliação
  • Leung DYM; National Jewish Health, Denver, Colorado. Electronic address: leungd@njhealth.org.
  • Paller AS; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Zaenglein AL; Penn State Health Hershey Medical Center, Hershey, Pennsylvania.
  • Tom WL; University of California, San Diego and Rady Children's Hospital, San Diego, California.
  • Ong PY; Children's Hospital Los Angeles, Los Angeles, California.
  • Venturanza ME; Incyte Corporation, Wilmington, Delaware.
  • Kuligowski ME; Incyte Corporation, Wilmington, Delaware.
  • Li Q; Incyte Corporation, Wilmington, Delaware.
  • Gong X; Incyte Corporation, Wilmington, Delaware.
  • Lee MS; Progressive Clinical Research, San Antonio, Texas.
Ann Allergy Asthma Immunol ; 130(4): 500-507.e3, 2023 04.
Article em En | MEDLINE | ID: mdl-36586583
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Inibidores de Janus Quinases Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Inibidores de Janus Quinases Idioma: En Ano de publicação: 2023 Tipo de documento: Article